In human malignancies, amplifications of FGF3 (Gruel et al., 2010) and FGFR2 (Kunii et al., 2008; Matsumoto et al., 2012; Su et al., 2014; Turner et al., 2010) are linked to breast and gastric cancer. This evidence concerns the gene FGF3 and gastric cancer.